Cargando…
Association of Fetal Growth Restriction With Neurocognitive Function After Repeated Antenatal Betamethasone Treatment vs Placebo: Secondary Analysis of the ACTORDS Randomized Clinical Trial
IMPORTANCE: Repeated doses of antenatal betamethasone are recommended for women at less than 32 weeks’ gestation with ongoing risk of preterm birth. However, concern that this therapy may be associated with adverse neurocognitive effects in children with fetal growth restriction (FGR) remains. OBJEC...
Autores principales: | Cartwright, Robert D., Crowther, Caroline A., Anderson, Peter J., Harding, Jane E., Doyle, Lex W., McKinlay, Christopher J. D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484607/ https://www.ncbi.nlm.nih.gov/pubmed/30707225 http://dx.doi.org/10.1001/jamanetworkopen.2018.7636 |
Ejemplares similares
-
Does Antenatal Betamethasone Alter White Matter Brain Development in Growth Restricted Fetal Sheep?
por: Sutherland, Amy E., et al.
Publicado: (2020) -
Neonatal Cardiovascular Function after Antenatal Sildenafil for Severe, Early-Onset Intrauterine Growth Restriction: A Substudy of the STRIDER-NZAus Randomized Placebo-Controlled Trial
por: Harris, Sarah L., et al.
Publicado: (2019) -
Comparing the Effects of Antenatal Betamethasone on Doppler Velocimetry Between Intrauterine Growth Restriction With and Without Preeclampsia
por: Shojaei, Kobra, et al.
Publicado: (2015) -
Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: A secondary analysis of the ASTEROID Trial
por: Hofer, Olivia J., et al.
Publicado: (2022) -
Antenatal Betamethasone Induces Increased Surfactant Proteins and Decreased Foxm1 Expressions in Fetal Rabbit Pups
por: Choi, Yong-Sung, et al.
Publicado: (2021)